NYSE:IQV IQVIA (IQV) Stock Price, News & Analysis $265.44 +3.67 (+1.40%) As of 11:56 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About IQVIA Stock (NYSE:IQV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IQVIA alerts:Sign Up Key Stats Today's Range$262.56▼$267.9550-Day Range$198.96▼$271.2252-Week Range$154.50▼$271.80Volume435,375 shsAverage Volume1.72 million shsMarket Capitalization$43.69 billionP/E Ratio32.95Dividend YieldN/APrice Target$243.63Consensus RatingModerate Buy Company Overview IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and contract research services for the life sciences industry. The company supports pharmaceutical, biotechnology and medical device companies throughout the product life cycle, from research and clinical development through commercialization and post-market activities. Its offerings include clinical trial management, site and patient services, real-world evidence, healthcare data, regulatory and safety services, commercial analytics, consulting, and technology platforms. IQVIA combines healthcare information with analytics and technology to help customers design studies, evaluate treatments, understand markets, improve patient engagement and support healthcare decision-making. The company was formed through the 2016 merger of Quintiles Transnational Holdings and IMS Health and adopted the IQVIA name in 2017. Headquartered in Durham, North Carolina, IQVIA serves customers across global markets. Ari Bousbib has served as the company’s chairman and chief executive officer since the merger.AI Generated. May Contain Errors. Read More IQVIA Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks70th Percentile Overall ScoreIQV MarketRank™: IQVIA scored higher than 70% of companies evaluated by MarketBeat, and ranked 195th out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingIQVIA has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 1 strong buy rating, 13 buy ratings, 3 hold ratings, and no sell ratings.Downside RiskIQVIA has a consensus price target of $243.63, representing about 7.0% downside from its current price of $262.09.Amount of Analyst CoverageIQVIA has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about IQVIA's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth11.50% Earnings GrowthEarnings for IQVIA are expected to grow by 11.50% in the coming year, from $11.57 to $12.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IQVIA is 32.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.19.Price to Earnings Ratio vs. SectorThe P/E ratio of IQVIA is 32.52, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.24.Price to Earnings Growth RatioIQVIA has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioIQVIA has a P/B Ratio of 6.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about IQVIA's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.33% of the float of IQVIA has been sold short.Short Interest Ratio / Days to CoverIQVIA has a short interest ratio ("days to cover") of 2.85, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IQVIA has recently decreased by 11.11%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIQVIA does not currently pay a dividend.Dividend GrowthIQVIA does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment0.98 News SentimentIQVIA has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 18 news articles for IQVIA this week, compared to 8 articles on an average week.Search InterestOnly 4 people have searched for IQV on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added IQVIA to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, IQVIA insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,796,021.00 in company stock.Percentage Held by Insiders1.70% of the stock of IQVIA is held by insiders.Percentage Held by Institutions89.62% of the stock of IQVIA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about IQVIA's insider trading history. Receive IQV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IQVIA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IQV Stock News HeadlinesIQVIA (NYSE:IQV) Upgraded to "Buy" at Wall Street ZenSeptember 12 at 1:24 AM | americanbankingnews.comIQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?September 10, 2026 | finance.yahoo.comGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet production stayed at 5.9 million ounces, unchanged from 2020. Newmont, Barrick and Agnico all face the same reserve shortage, pushing majors toward acquiring smaller producing miners. Recent deals show the pattern: Rupert Resources jumped 67 percent and G2 Goldfields jumped 79 percent the day their buyouts were announced. Analyst Garrett Goggin has identified four junior miners he believes are next on the shopping list.September 14 at 1:00 AM | Golden Portfolio (Ad)IQVIA prices $2B of senior notes due 2034September 9, 2026 | msn.comIQVIA Holdings Announces $2 Billion Senior Notes OfferingSeptember 9, 2026 | tipranks.comIQVIA Announces Pricing of Senior NotesSeptember 9, 2026 | businesswire.comIQVIA (IQV): Buy, sell, or hold post Q2 earnings?September 8, 2026 | msn.comJames Berkshire Sells 2,668 Shares of IQVIA (NYSE:IQV) StockSeptember 5, 2026 | insidertrades.comSee More Headlines IQV Stock Analysis - Frequently Asked Questions How have IQV shares performed this year? IQVIA's stock was trading at $225.40 on January 1st, 2026. Since then, IQV shares have increased by 16.3% and is now trading at $262.0940. How were IQVIA's earnings last quarter? IQVIA Holdings Inc. (NYSE:IQV) issued its quarterly earnings data on Tuesday, July, 28th. The medical research company reported $3.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.03 by $0.12. IQVIA's revenue for the quarter was up 8.7% compared to the same quarter last year. Read the conference call transcript. Is IQVIA buying back stock? IQVIA's Board of Directors approved a stock buyback plan on Thursday, May 7th 2026, which allows the company to repurchase $2,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 6.8% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's management believes its stock is undervalued. Does IQVIA have any subsidiaries? IQVIA subsidiaries include Q2 Solutions, Linguamatics, Advanced Health Media LLC, DrugDev, Aileron Solutions, Novella Clinical LLC, 159 Solutions LLC, and others. When did IQVIA IPO? IQVIA (IQV) raised $900 million in an initial public offering on Thursday, May 9th 2013. The company issued 23,684,210 shares at $36.00-$40.00 per share. Who are IQVIA's major shareholders? Top institutional shareholders of IQVIA include California State Teachers Retirement System (29.92%), BlackRock Inc. (8.84%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (0.99%) and Canada Pension Plan Investment Board (0.76%). Insiders that own company stock include Ari Bousbib, Eric Sherbet, Constantinos Panagos, W Richard Staub, James G Berkshire, Kevin C Knightly, Keriann Cherofsky, Bhavik Patel and John G Danhakl. View institutional ownership trends. How do I buy shares of IQVIA? Shares of IQV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IQVIA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IQVIA investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Bristol Myers Squibb (BMY), Advanced Micro Devices (AMD), Broadcom (AVGO) and McKesson (MCK). Company Calendar Last Earnings7/28/2026Today9/14/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 IQV's financial health is in the Green zone, according to TradeSmith. IQV has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:IQV CIK1478242 Webwww.iqvia.com Phone(919) 998-2000FaxN/AEmployees93,000Year Founded2016Price Target and Rating Average Price Target for IQVIA$243.63 High Price Target$288.00 Low Price Target$185.00 Potential Upside/Downside-7.9%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)$8.06 Trailing P/E Ratio32.80 Forward P/E Ratio22.85 P/E Growth2.24Net Income$1.36 billion Net Margins8.10% Pretax Margin9.27% Return on Equity30.25% Return on Assets6.54% Debt Debt-to-Equity Ratio2.18 Current Ratio0.71 Quick Ratio0.71 Sales & Book Value Annual Sales$16.31 billion Price / Sales2.67 Cash Flow$18.05 per share Price / Cash Flow14.65 Book Value$38.93 per share Price / Book6.79Miscellaneous Outstanding Shares164,600,000Free Float161,802,000Market Cap$43.52 billion OptionableOptionable Beta1.18 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:IQV) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredWhat is Elon Building in Texas?Elon Musk's latest Texas project is massive - three times the size of Central Park and backed by a reported 12...InvestorPlace | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredElon Musk to Trigger Next AI Wave on November 11th?Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQVIA Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IQVIA With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
